| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.40B | 80.24B | 72.22B | 79.43B | 80.52B | 70.57B |
| Gross Profit | 16.90B | 16.09B | 11.68B | 11.57B | 17.97B | 16.69B |
| EBITDA | 7.77B | 9.00B | 4.76B | 49.00M | 6.29B | 7.14B |
| Net Income | 1.71B | 2.64B | -1.04B | -4.94B | 1.50B | 2.17B |
Balance Sheet | ||||||
| Total Assets | 126.62B | 122.30B | 125.42B | 119.03B | 117.74B | 105.76B |
| Cash, Cash Equivalents and Short-Term Investments | 9.40B | 9.43B | 11.58B | 11.14B | 10.37B | 8.46B |
| Total Debt | 42.72B | 39.41B | 42.42B | 35.16B | 26.87B | 21.98B |
| Total Liabilities | 69.73B | 65.06B | 68.50B | 62.52B | 55.16B | 47.16B |
| Stockholders Equity | 59.25B | 58.47B | 56.13B | 54.08B | 59.18B | 57.23B |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | 712.00M | -5.70B | -6.69B | -2.43B | -2.34B |
| Operating Cash Flow | 2.99B | 5.12B | 1.16B | -575.00M | 3.99B | 3.69B |
| Investing Cash Flow | -3.31B | -3.24B | -7.14B | -6.05B | -7.40B | -7.30B |
| Financing Cash Flow | -84.00M | -4.70B | 5.48B | 6.67B | 4.93B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥31.48B | 9.15 | ― | 2.47% | 3.53% | 8.36% | |
77 Outperform | ¥26.06B | 6.28 | ― | 3.63% | 18.02% | 18.04% | |
76 Outperform | ¥24.45B | 6.46 | ― | 3.21% | 9.61% | 173.72% | |
75 Outperform | ¥54.38B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
72 Outperform | ¥25.09B | 12.16 | ― | 3.84% | -3.41% | -12.83% | |
62 Neutral | ¥24.72B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |